BioSpace News Archive

Business

Egret Therapeutics Announces the Addition of Three New Members to its Scientific Advisory Board

Egret Therapeutics, a clinical-stage company focused on the treatment of neurological diseases, announced the expansion of its Scientific Advisory Board with the appointment of three new members:

January 3, 2023
·
3 min read
Genetown

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 03, 2023

Cullinan Oncology, Inc. announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 37,000 shares of its common stock to three employees outside Cullinan Oncology, Inc’s 2021 Stock Option and Incentive Plan.

January 3, 2023
·
2 min read
argenx to Present at 41st Annual J.P. Morgan Healthcare Conference

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 9:00 a.m. PT.

January 3, 2023
·
1 min read
New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursement

Photocure ASA, The Bladder Cancer Company, announces the publication of the study ‘Clinical and Economic Impact of Blue Light Cystoscopy in the Management of NMIBC* at U.S. Ambulatory Surgical Centers: What is the Site-of-Service Disparity?’ in Urologic Oncology this week.

January 3, 2023
·
6 min read
Drug Development

HUTCHMED Completes Patient Enrollment of ESLIM-01, a Phase III Trial of Sovleplenib in Primary Immune Thrombocytopenia in China

HUTCHMED Limited announces that it has completed patient enrollment of ESLIM-01, a pivotal Phase III clinical trial of sovleplenib for the treatment of adult patients with primary immune thrombocytopenia in China.

January 3, 2023
·
6 min read
BioMidwest

Exact Sciences to participate in J.P. Morgan Healthcare Conference 2023

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, announced that company management will participate in the following conference and invited investors to participate by webcast.

January 3, 2023
·
1 min read
Business

Protalix BioTherapeutics Issues 2023 Letter to Stockholders

Protalix BioTherapeutics, Inc. today announced the following letter from its President and Chief Executive Officer, Dror Bashan, to its stockholders and the investment community.

January 3, 2023
·
10 min read
Genetown

Apellis Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

Apellis Pharmaceuticals, Inc. announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 9:00 a.m. PT / 12:00 p.m. ET.

January 3, 2023
·
1 min read
Pharm Country

Tonix Pharmaceuticals to Present at Biotech Showcase 2023

Tonix Pharmaceuticals Holding Corp. announced that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, will present at Biotech Showcase 2023 being held January 9-11, 2023, at the Hilton San Francisco Union Square.

January 3, 2023
·
5 min read
Pharm Country

IN8bio to Present at Biotech Showcase 2023 in San Francisco

IN8bio, Inc. announced William Ho, CEO and co-founder, will present at Biotech Showcase 2023 on Monday, January 9, 2023, and will also participate in a panel on Tuesday, January 10, 2023, at the Hilton San Francisco Union Square Hotel in San Francisco, CA.

January 3, 2023
·
2 min read